--- a
+++ b/clusters/3009knumclusters/clust_9.txt
@@ -0,0 +1,825 @@
+Must have a life expectancy of at least 12 weeks
+Life expectancy greater than (>) 12 weeks
+Patients must have a life expectancy of >= 8 weeks
+Life expectancy of greater than 12 weeks
+The patient has a life expectancy of >= 16 weeks
+Life expectancy of greater than 12 weeks
+Life expectancy ? 12 weeks.
+No comorbid conditions that would cause life expectancy of less than 5 years
+Patients must have a life expectancy >= 12 weeks
+Patients must have a life expectancy of >= 12 weeks as determined clinically by the treating physician
+Patients must have a life expectancy of >= 8 weeks
+Life expectancy of 12 weeks or more
+Participant must have a life expectancy >= 16 weeks
+Life expectancy of at least 12 weeks based on investigator estimate
+Life expectancy of >=12 weeks
+Life expectancy of at least 4 weeks
+Life expectancy of greater than 12 weeks
+Life expectancy of at least 12 weeks
+Life expectancy of greater than 12 weeks
+WHO/ECOG performance status 0 to 1 with no deterioration over the previous 2 weeks and min life expectancy of 12 weeks
+Participants must have an estimated life expectancy of > 6 weeks
+Life expectancy must be >= 8 weeks
+Life expectancy > 12 weeks as determined by the Investigator.
+Life expectancy >= 16 weeks
+Minimum life expectancy of 12 weeks
+Estimated life expectancy of at least 90 days
+Life expectancy of >= 12 weeks
+Life expectancy of at least 12 weeks
+Estimated life expectancy greater than 3 years
+Life expectancy >= 12 weeks
+Life expectancy of >= 12 weeks
+Life expectancy ? 12 weeks
+Patients with life expectancy >= 12 weeks
+Life expectancy ? 18 weeks
+Life expectancy > 12 weeks as determined by the Investigator.
+Patients must have a life expectancy of >= 12 weeks
+Life expectancy at least 12 weeks
+Life expectancy <2 years
+Life expectancy of greater than 3 weeks
+Life expectancy of greater than 6 weeks
+COHORT 1: A projected life expectancy of at least 12 weeks
+COHORT 2: A projected life expectancy of at least 12 weeks
+Life expectancy is greater than 12 weeks.
+Life expectancy at least 12 weeks
+Patients must have a life expectancy of at least 12 weeks at the time of registration
+Patients must have a life expectancy ?12 weeks.
+Life expectancy of greater than or equal to (>=12) weeks
+Life expectancy of 12 or more weeks
+Life expectancy >= 16 weeks
+Life expectancy > 12 weeks.
+Life expectancy greater than or equal to 12 weeks
+Life expectancy of at least 12 weeks.
+Life expectancy of greater than 12 weeks
+Life expectancy ?18 weeks
+Life expectancy of greater than 12 weeks
+Life expectancy <12 weeks.
+Life expectancy greater than 12 weeks.
+Life expectancy >= 6 weeks
+Life expectancy of > 8 weeks
+Subject must have a life expectancy >= 2 years
+Life expectancy of < 1 year
+Estimated life expectancy >= 12 weeks
+PROCUREMENT: Patients with life expectancy >= 6 weeks
+TREATMENT: Patients with life expectancy >= 6 weeks
+Life expectancy of greater than 1 year
+Patients must have a life expectancy of greater than or equal to 8 weeks.
+Life expectancy of at least 12 weeks or greater
+Life expectancy of at least 12 weeks or greater
+Patients whose life expectancy is limited by illness other than their neurological condition
+Patients with life expectancy >= 6 weeks from time of CTL infusion
+Life expectancy of greater than 8 weeks
+The subject has a life expectancy of greater than 12 weeks.
+Life expectancy of greater than or equal to (>/=)12 weeks
+ECOG/WHO performance status of 0 to 1, and a minimum life expectancy of 12 weeks.
+Life expectancy > 12 weeks at Screening
+Life expectancy >12 weeks.
+Participants must have a life expectancy of greater than 12 weeks
+Life expectancy >/=12 weeks
+Have an estimated life expectancy of 12 weeks, in judgement of the investigator.
+PROCUREMENT INCLUSION CRITERIA: Patients with life expectancy ? 12 weeks
+Patients with life expectancy ? 12 weeks
+INCLUSION - PROCUREMENT: Life expectancy greater than 12 weeks
+INCLUSION - TREATMENT: Life expectancy of greater than 12 weeks
+Life expectancy ? 12 weeks
+No prior primary or metastatic brain or meningeal tumors unless clinically and radiographically stable as well as off steroid therapy for at least 2 months; 10a. Life expectancy ?8 weeks all (US); 10b. Life expectancy ?12 weeks; ? 8 weeks superficial tumors (Canada);
+Life expectancy of greater than 12 weeks
+Life expectancy greater than or equal to (>/=) 12 weeks
+Life expectancy greater than or equal to (>/=) 12 weeks
+Life expectancy of greater than 12 weeks
+Must have life-expectancy of > 12 weeks.
+INCLUSION - PROCUREMENT: Life expectancy of greater than 6 weeks
+INCLUSION - INFUSION: Patients with life expectancy ? 6 weeks
+Life expectancy of at least 12 weeks
+Life expectancy >/=18 weeks
+Life expectancy at least 12 weeks
+Life expectancy of at least 12 weeks
+Life expectancy ?12 weeks.
+Life expectancy > 12 weeks.
+Life expectancy ?3 mos
+Life expectancy ?3 years, as judged by the site investigator
+Life expectancy ? 6 weeks
+Life expectancy of ?12 weeks.
+Life expectancy >10 weeks;
+Life expectancy ? 6 weeks
+Life expectancy >/= 12 weeks
+PHASE I: Life expectancy >= 12 weeks
+PHASE IB: Life expectancy >= 12 weeks
+Life expectancy >= 12 weeks
+Life expectancy, in the opinion of the investigator, greater than or equal to (>=) 12 weeks
+Patient has life expectancy ? 6 weeks.
+ELIGIBILITY CRITERIA AT TIME OF TREATMENT: Patients with life expectancy ? 6 weeks
+PROCUREMENT INCLUSION CRITERIA: Patients with life expectancy ? 6 weeks
+Patients with life expectancy ? 6 weeks
+Patients must have a life expectancy of >= 12 weeks
+Life expectancy of greater than 8 weeks in the opinion of the referring clinician
+Estimated life expectancy > 12 weeks
+Life expectancy of ? 12 weeks
+Life expectancy ? 6 weeks
+Patients must have a life expectancy of > 8 weeks
+Patients must have a life expectancy of greater than 8 weeks
+Life expectancy >= 90 days
+Life expectancy of greater than 12 weeks
+Life expectancy greater than 12 weeks
+Life expectancy >= 12 weeks
+Patients must have a life expectancy of at least 12 weeks
+Life expectancy of greater than 12 weeks
+Life expectancy >= 8 weeks
+Subjects must have a life expectancy of >= 8 weeks
+Patients with a life expectancy of less than 2 years
+AUTOLOGOUS APHERESIS: Estimated life expectancy of > 12 weeks
+MANUFACTURING SJCAR19: Estimated life expectancy of > 12 weeks
+TREATMENT WITH SJCAR19: Estimated life expectancy of > 8 weeks
+Life expectancy of greater than 12 weeks measured from the date of completion of radiotherapy.
+Patients must have a life expectancy of >= 16 weeks
+Subject must have a projected life expectancy of at least 12 weeks
+Life expectancy >= 12 weeks
+Life expectancy >= 12 weeks
+Life expectancy of at least 12 weeks
+A life expectancy of greater than 24 weeks at Screening.
+Life expectancy >= 12 weeks as judged by the treating physician.
+Life expectancy ? 12 weeks
+Life expectancy >= 12 weeks
+Life expectancy >= 90 days
+Life expectancy ? 12 weeks
+Subject has a life expectancy of at least 12 weeks
+Life expectancy > 4 weeks
+Must have a life expectancy greater than or equal to 16 weeks
+Minimum life expectancy of at least 12 weeks
+Life expectancy of greater than 12 weeks
+Participant must have a projected life expectancy of at least 12 weeks.
+Life expectancy ? 12 weeks
+Life expectancy ? 12 weeks
+Life expectancy ? 12 weeks
+Co-existing medical conditions with life expectancy < 5 years
+Subjects must have a life expectancy of > 8 weeks
+Life expectancy less than 10 years;
+Life expectancy of at least 2 years
+Expected life expectancy >= 12 weeks
+Life expectancy of greater than 12 weeks
+Subjects must have a life expectancy >= 12 weeks.
+Life expectancy of >= 12 weeks
+Estimated life expectancy > 12 weeks at randomization;
+Life expectancy > 12 weeks
+Patients should have life expectancy >= 10 weeks.
+Subjects must have a life expectancy of > 8 weeks
+Minimum life expectancy of at least 12 weeks. Expanded Safety Phase:
+Life expectancy of at least 12 weeks.
+Patients with any severe concomitant disease that may limit their life expectancy to less than 5 years
+The subject has a life expectancy of 12 weeks or greater
+Life expectancy >= 12 weeks
+Life expectancy of >= 52 weeks.
+Life expectancy of greater than 12 weeks
+Life expectancy >= 12 weeks
+Life expectancy of >= 12 weeks
+Estimated life expectancy >12 weeks
+Life expectancy > 12 weeks
+Life expectancy of less than 12 weeks
+Life expectancy less than 2 years
+Life expectancy of >= 16 weeks
+Life expectancy of greater than 8 weeks
+Life expectancy of 12 weeks or more
+Life expectancy >= 12 weeks
+Life expectancy ? 12 weeks.
+Life expectancy of >= 12 weeks based on investigator estimate
+Life expectancy of greater than 12 weeks measured from the date of completion of radiotherapy
+Life expectancy of >= 12 weeks
+Participant must have a projected life expectancy of at least 12 weeks.
+Life expectancy of ? 12 weeks
+Participants must have a life expectancy >= 16 weeks
+Life expectancy of greater than 12 weeks
+Have a life expectancy >= 6 weeks
+Have life expectancy of >=8 weeks.
+Life expectancy >= 12 weeks
+CELL PROCUREMENT: Life expectancy >= 12 weeks
+LYMPHODEPLETION: Life expectancy >= 12 weeks
+Life expectancy > 24 weeks
+Life expectancy of > 12 weeks
+Life expectancy of greater than 12 weeks
+Life expectancy of >= 12 weeks as determined by treating investigator
+Have at least 6 month life expectancy
+Life expectancy of at least 12 weeks after the start of the treatment according to the Investigator's judgement
+Life expectancy of at least 12 weeks
+Subjects must have a life expectancy of at least 12 weeks, in the opinion of the investigator.
+Life expectancy, in the clinician's judgment, greater than 1 year
+Life expectancy greater than 12 weeks.
+Life expectancy > 12 weeks
+Life expectancy of greater than 12 weeks
+Life expectancy >12 weeks as judged by investigators
+Life expectancy >= 12 weeks
+Minimal life expectancy of 12 weeks
+Life expectancy of >= 12 weeks (per treating investigator’s discretion)
+Have an estimated life expectancy of ?12 weeks, in the judgment of the investigator.
+Life expectancy of >= 12 weeks.
+Estimated life expectancy ? 12 weeks (according to investigator's judgement)
+Life expectancy ?12 weeks
+Life expectancy of greater than 12 weeks
+Life expectancy >= 12 weeks
+Life expectancy >= 10 years (as determined by the treating physician)
+Patients must have a predicted life expectancy of at least 12 weeks.
+Life expectancy >= 12 weeks
+Patients must have a life expectancy of > 12 weeks
+Life expectancy > 12 weeks
+Subject must have a life expectancy >= 12 weeks
+Life expectancy greater than 10 weeks
+Life expectancy without treatment > 12 weeks
+Life expectancy >=12 weeks
+Life expectancy >= 12 weeks
+CAPMATINIB INCLUSION CRITERIA: Life expectancy >= 12 weeks
+CERITINIB INCLUSION CRITERIA: Life expectancy >= 12 weeks
+REGORAFENIB INCLUSION CRITERIA: Life expectancy >= 12 weeks
+Subjects must have a life expectancy of at least 4 weeks
+Life expectancy >= 12 weeks
+Subject must have a life expectancy of >= 8 weeks.
+Life expectancy of 12 weeks and more
+Life expectancy > 12 weeks
+A life expectancy of at least 12 weeks with a Karnofsky performance status of at least 50
+Anticipated life expectancy >12 weeks
+Life expectancy > 8 weeks
+Life expectancy < 12 weeks
+Patient must have a life expectancy of > 8 weeks
+Life expectancy of at least 12 weeks in the opinion of investigator
+Estimated life expectancy, in the judgment of the investigator, which will permit receipt of treatment of 12 weeks or more
+Patients must have a life expectancy of at least 12 weeks
+Patients must have a life expectancy >= 16 weeks
+Life expectancy of at least 12 weeks
+Life expectancy ? 12 weeks
+AT THE TIME OF INFUSION: Life expectancy ? 6 weeks
+Life expectancy: at least 8 weeks
+Life expectancy: must be >= 12 weeks
+Life expectancy of greater than 12 weeks
+TREATMENT: Life expectancy ? 6 weeks
+Estimated life expectancy of at least 12 weeks
+Life expectancy >= 52 weeks excluding their diagnosis of breast cancer
+Patient must have a life expectancy of >= 8 weeks
+Life expectancy of at least 12 weeks
+Life expectancy of at least 16 weeks
+PROCUREMENT: Patients with life expectancy ? 6 weeks
+TREATMENT: Patients with life expectancy ? 6 weeks
+Have a life expectancy of >= 12 weeks
+Life expectancy > 12 weeks
+Life expectancy of at least 12 weeks in opinion of principal investigator (PI) and/or designee
+Life expectancy of at least 12 weeks in the opinion of investigator
+Life expectancy >= 16 weeks
+Life expectancy > 4 weeks
+Life expectancy >8 weeks.
+Patients must have a life expectancy of greater than or equal to 8 weeks
+A life expectancy >= 16 weeks at time of enrollment
+Life expectancy >= 16 weeks at time of screening
+Life expectancy >= 16 weeks at time of enrollment
+A life expectancy of at least 3 weeks, even if requiring artificial ventilation.
+Life expectancy of > 12 weeks, in the opinion of and as documented by the investigator
+Life expectancy of ? 6 weeks.
+Life expectancy of at least 12 weeks
+Life expectancy >= 12 weeks
+Life expectancy of at least 5 years
+Life expectancy of >= 3 years (yrs)
+Life expectancy of greater than 4 weeks
+A life expectancy of at least 12 weeks with a Karnofsky performance status of at least 70
+Life expectancy > 12 weeks
+Life expectancy > 8 weeks
+Life expectancy > 12 weeks
+At least 12 month life expectancy
+Life expectancy of greater than 12 weeks
+Life expectancy more than 12 weeks
+Patients must have a life expectancy of at least 4 weeks
+Life expectancy > 5 years
+Life expectancy of greater than 12 weeks
+Patients must have a life expectancy of at least 8 weeks
+Life expectancy of greater than 12 weeks
+Must have a life expectancy of at least 5 years based on age and co-morbidities.
+Life expectancy >= 12 weeks
+A life expectancy > 12 weeks
+Patients with life expectancy >= 6 weeks
+Life expectancy > 12 weeks in the opinion of the investigator
+Life expectancy > 12 weeks
+A life expectancy of at least 6 weeks
+Life expectancy > 12 weeks
+Life expectancy ? 12 weeks.
+Life expectancy > 12 weeks or ? 24 weeks for Part 3 and Part 4 MF subjects.
+Estimated life expectancy of > 12 weeks, as assessed by the site investigator
+Have a life expectancy ?12 weeks.
+Life expectancy of greater than 2 years
+Life expectancy of greater than 5 years
+Estimated life expectancy > 12 weeks
+Life expectancy: must be >= 8 weeks
+Life expectancy greater than 12 weeks
+Minimum life expectancy of six weeks as determined by consenting professional
+No life expectancy restrictions will apply
+Life expectancy severely limited by disease other than malignancy
+Life expectancy ? 12 weeks.
+Life expectancy of >= 10 years as determined by treating physician
+Patients with co-existing medical conditions with life expectancy < 2 years
+Life expectancy >= 6 weeks
+Life expectancy greater than 8 weeks
+Patients with a life expectancy (=< 6 weeks) limited by diseases other than leukemia
+A serious underlying medical condition other than NSCLC such that life expectancy is less than 2 years.
+Minimum life expectancy of eight weeks
+Subject has predicted life expectancy ? 12 weeks.
+Life expectancy of at least 12 weeks.
+Life expectancy >= 12 weeks
+Life expectancy ?12 weeks
+Life expectancy of greater than 12 weeks
+Life expectancy of ? 12 weeks in the opinion of the Investigator
+Life expectancy ? 12 weeks.
+Life expectancy of ? 12 weeks, as per investigator.
+Life expectancy ?12 weeks
+Predicted life expectancy ?12 weeks.
+Subject has a life expectancy of ? 12 weeks
+Life expectancy >/=12 weeks.
+Life expectancy of at least 90 days
+Life expectancy of > 12 weeks from screening, according to the investigator's assessment.
+Life expectancy of >= 12 weeks
+Life expectancy of at least 6 weeks
+Life expectancy ?12 weeks
+Patients must have a life expectancy of at least 12 weeks and an ECOG performance status of 0, 1 or 2
+Age equal to or greater than 18 years and life expectancy > 10 weeks.
+Life expectancy of >= 1 year
+Life expectancy >4 weeks following initiation.
+Subjects who have a life expectancy of ?12 weeks.
+106 Minimum life expectancy of 12 weeks.
+Patients must have a life expectancy of greater or equal to 12 weeks
+Life expectancy of greater than 12 weeks
+Patients must have a life expectancy >= 16 weeks.
+Patients must have a life expectancy ? 16 weeks
+Life expectancy >= 12 weeks
+Patients must have a life expectancy of at least 6 weeks
+Predicted life expectancy >= 16 weeks.
+Minimal life expectancy of 12 weeks.
+Life expectancy of >= 12 weeks
+Estimated life expectancy < 28 days in the opinion of the enrolling investigator
+Life expectancy > 12 weeks
+Other life-threatening illness that is expected to impact life expectancy within 3 years
+Patients must have a life expectancy >= 16 weeks.
+Life expectancy of >= 12 weeks
+Expected life expectancy of < 12 weeks as determined by the investigator
+The participant must have a life expectancy of greater than 12 weeks
+Life expectancy of > 12 weeks
+Life expectancy >= 12 weeks
+Life expectancy >12 weeks
+The subject must have a life expectancy of >= 8 weeks.
+Life expectancy of greater than 12 weeks
+Predicted life expectancy of at least 12 weeks.
+Life expectancy ? 12 weeks.
+Life expectancy of at least 12 weeks
+Life expectancy of > 5 years per the clinical impression of the treating physician(s)
+Life expectancy of at least 12 weeks
+The subject must have a life expectancy > 16 weeks
+Life expectancy >= 12 weeks
+Life expectancy >= 12 weeks
+ARM A: Life expectancy >= 12 weeks
+ARM B: Life expectancy >= 12 weeks
+Life expectancy >= 12 weeks (in the opinion of the enrolling investigator)
+Life expectancy of greater than 12 weeks
+Life expectancy >= 12 weeks
+Life expectancy of greater than 12 weeks
+Patients must have a life expectancy >= 16 weeks
+Subjects must have a life expectancy of at least 4 weeks
+Life expectancy of >= 2 years
+Life expectancy >= 12 weeks
+Life expectancy >= 12 weeks
+Life expectancy of greater than 16 weeks
+Patients must have a life expectancy of at least 12 weeks
+Estimated life expectancy of at least 12 weeks
+Life expectancy >12 weeks
+Patients whose life expectancy is severely limited by illness other than CD
+Life expectancy >= 12 weeks
+Patients whose life expectancy is limited by diseases other than their malignancy
+Patients must have a life expectancy of at least 6 weeks
+Life expectancy 12 weeks or more
+Patient must have a life expectancy > 8 weeks
+Life expectancy > 12 weeks
+Life expectancy of greater than 12 weeks
+Life expectancy > 12 weeks
+Life expectancy of >= 12 weeks
+< 10 years life expectancy
+Patients must have a life expectancy of >= 12 weeks
+PHASE II: Patients must have a life expectancy of >= 12 weeks
+Life expectancy of greater than 12 weeks
+Patients must have a life expectancy of >= 8 weeks
+Life expectancy of greater than 12 weeks
+With life expectancy severely limited by diseases other than malignancy
+Life expectancy of at least 12 weeks
+Life expectancy of >= 12 weeks
+Patients must have a life expectancy >= 16 weeks
+Life expectancy < 10 years
+Patients must have a life expectancy of at least 12 weeks
+Life expectancy of greater than 12 weeks.
+Estimated life expectancy of at least 12 weeks
+Patients must have a life expectancy of >= 8 weeks
+Life expectancy without treatment of at least 12 weeks
+Life expectancy >= 6 weeks
+Life expectancy of at least 12 weeks
+Life expectancy: greater than 8 weeks
+Life expectancy >2 years, in the opinion of the investigator
+Patients with a life expectancy > 12 weeks
+Life expectancy greater than or equal to (>/=) 12 weeks
+Life expectancy of > 12 weeks
+Minimum life expectancy of at least 12 weeks
+The participant has an estimated life expectancy of minimum 12 weeks.
+Life expectancy of > 12 weeks
+Life expectancy ? 12 weeks.
+Life expectancy > 12 weeks, for MF subjects in Parts 3 and 4, life expectancy > 24 weeks
+Life expectancy of > 12 weeks
+Life expectancy > 12 weeks.
+Life expectancy > 10 weeks
+Life expectancy of at least 12 weeks.
+Estimated life expectancy of more than 12 weeks
+Life expectancy more than 12 weeks
+Life expectancy > 12 weeks
+Life expectancy of at least 12 weeks.
+Life expectancy ?12 weeks
+Life expectancy, in the opinion of the investigator of greater than or equal (>/=) to 12 weeks
+Life expectancy < 12 weeks
+Life expectancy of >/= 12 weeks
+Life expectancy greater than or equal to (>/=) 12 weeks
+Estimated Life Expectancy of at least 3 mo
+Life expectancy ? 10 years
+Life expectancy ? 12 weeks.
+Life expectancy > 12 weeks.
+Life expectancy of at least 12 weeks
+Have an anticipated life expectancy of greater than 8 weeks.
+Participant must have a life expectancy greater than 12 weeks,
+Life expectancy of at least 5 years, disregarding the diagnosis of cancer;
+Patients must have a life expectancy ? 16 weeks
+Life expectancy greater than or equal to (>=) 12 weeks
+Estimated life expectancy of more than 12 weeks
+Life expectancy of at least 12 weeks
+Life expectancy of greater than 12 weeks
+Life expectancy severely limited by diseases other than malignancy
+Life expectancy ?12 weeks
+Life expectancy must be greater than 60 days
+Life expectancy of greater than 12 weeks
+Life expectancy of 12 weeks or more
+Patients with other active malignancies (no evidence of other cancer or life expectancy greater than 5 years) are ineligible for this study
+Life expectancy ? 10 years.
+Life expectancy of >= 12 weeks
+Subjects must have a life expectancy of at least 12 weeks
+Has a life expectancy of ?16 weeks
+Predicted life expectancy ?12 weeks. Inclusion Criteria Specific for Part A:
+Life expectancy at least 12 weeks
+Life expectancy of at least 12 weeks
+Life expectancy > 12 weeks
+Life expectancy > 12 weeks
+Life expectancy >12 weeks
+Patients with a life expectancy greater than 1 month
+Have an estimated life expectancy of ?12 weeks in the judgment of the investigator.
+Life expectancy >= 12 weeks
+Life expectancy of greater than 12 weeks
+Life expectancy ? 12 weeks
+Have an estimated life expectancy of ?12 weeks.
+Life expectancy of at least 12 weeks
+Life expectancy of 12 weeks or longer
+Life expectancy of > 24 weeks
+Life expectancy of greater than 12 weeks
+Life expectancy > 12 weeks
+Life expectancy of at least 5 years
+Life expectancy < 90 days.
+Life expectancy of at least 8 weeks
+Life expectancy >= 6 weeks
+Participants must have a life expectancy of at least 8 weeks
+Life expectancy >= 12 weeks
+Have a life expectancy of at least 12 weeks.
+Life expectancy >= 12 weeks
+Subject has a life expectancy of at least 12 weeks.
+Life expectancy ?12 weeks
+Life expectancy of greater than 12 weeks
+Life expectancy >= 12 weeks as judged by the Investigator
+Life expectancy > 12 weeks
+Life expectancy of at least 1 year
+Patient must have a predicted life expectancy of at least 12 weeks.
+Patients must have a life expectancy of >= 90 days
+Life expectancy >12 weeks.
+Life expectancy <16 weeks
+Patients must have a life expectancy of greater than 12 weeks
+Subjects must have a life expectancy of at least 12 weeks.
+Life expectancy 12 weeks or more
+The participant has an estimated life expectancy of 12 weeks in the judgment of the investigator.
+Life expectancy > 5 years
+Life expectancy of at least 12 weeks.
+Estimated life expectancy more than 12 weeks
+Anticipated life expectancy ? 12 weeks
+Life expectancy of at least 12 weeks.
+Life expectancy >= 12 weeks
+Life expectancy of greater than 12 weeks
+Life expectancy greater than or equal to (>/=) 12 weeks
+Subject must have a projected life expectancy of at least 12 weeks.
+Patients must have a life expectancy ? 24 weeks.
+Subject must be ? 18 years of age. Life expectancy > 12 weeks.
+Patients must have a life expectancy of at least one year
+Life expectancy of greater than 8 weeks
+Life expectancy > 12 weeks
+Life expectancy of greater than 12 weeks
+Predicted life expectancy ?12 weeks.
+Estimated life expectancy of more than 12 weeks.
+Life expectancy greater than or equal to (>=) 12 weeks
+Life expectancy > 12 weeks
+Life expectancy > 24 weeks
+Life expectancy of at least 12 weeks (3 months) as determined by the investigator
+Life expectancy of at least 12 weeks
+Estimated life expectancy of more than 12 weeks
+Patients must have a life expectancy of at least 8 weeks
+AT THE TIME OF INFUSION: Patients with life expectancy ? 6 weeks
+Life expectancy >= 16 weeks at time of enrollment
+Patients must have a life expectancy >= 90 days
+Predicted life expectancy of at least 12 weeks.
+Life expectancy of greater than 1 year
+Life expectancy > 1 month
+Life expectancy greater than or equal to (>/=) 12 weeks
+Life expectancy < 3 years
+Patients must have a life expectancy ?12 weeks.
+Life expectancy of >12 weeks.
+Estimated life expectancy of >= 5 years
+Life expectancy is greater than 1 year
+Life expectancy of greater than 12 weeks
+At least 6-month life expectancy.
+Patients must have a life expectancy >= 16 weeks.
+Life expectancy > 10 years based on clinician’s judgment
+Life expectancy of greater than 12 weeks
+Life expectancy less than 1 month
+Patients must have a life expectancy of >= 12 weeks
+Life expectancy of greater than 12 weeks
+Life expectancy >= 12 weeks
+Life expectancy >= 3 mos
+Life expectancy of greater than 4 weeks
+Life expectancy of greater than 12 weeks
+Patient must have life expectancy >= 12 weeks
+Subjects must have a life expectancy of at least 4 weeks
+Patients must have a life expectancy of >= 8 weeks (>= 56 days)
+Life expectancy >= 12 weeks
+Life expectancy of greater than 1 year
+Life expectancy ? 12 weeks
+Life-expectancy based on comorbid conditions > 2 years
+Life expectancy >= 12 weeks
+Life expectancy of >= 12 weeks
+Life expectancy of greater than or equal to (>=) 12 weeks
+Patients must have a life expectancy of greater than 12 weeks
+Life expectancy greater than 12 weeks
+Subjects must have a life expectancy of equal to or greater than 8 weeks
+Life expectancy >= 12 weeks
+Life expectancy of greater than 1 month
+Life expectancy of greater than 12 weeks
+Life expectancy of ?12 weeks
+Life expectancy from a co-morbid illness > 3 years
+Life expectancy of >= 12 weeks
+Life expectancy of greater than 12 weeks
+Life expectancy >= 12 weeks
+Life expectancy > 12 weeks
+Life expectancy of greater than 12 weeks
+Life expectancy of >= 8 weeks
+Life expectancy of >= 16 weeks
+Life expectancy of greater than 1 month
+Estimated life expectancy of ?12 weeks
+Predicted life expectancy of at least 12 weeks
+Have an estimated life expectancy of greater than or equal to 12 weeks
+Life expectancy >= 12 weeks
+Life expectancy greater than or equal to (>=) 12 weeks
+Life expectancy > 12 weeks
+Life expectancy >= 12 weeks
+Life expectancy of greater than 12 weeks
+Life expectancy >= 12 weeks
+Life expectancy of less than 12 weeks
+Life expectancy of at least 3 years
+Life expectancy > 8 weeks
+Life expectancy > 12 weeks.
+Life expectancy of at least 12 weeks
+Life expectancy of >= 12 weeks
+Life expectancy > 4 weeks
+Life expectancy of >= 12 weeks
+Life expectancy ? 12 weeks.
+Subjects must have a life expectancy greater than or equal to 16 weeks;
+Life expectancy of greater than 9 weeks
+The patient must have a life expectancy of at least 12 weeks
+Life expectancy of ? 12 weeks
+Life expectancy of greater than 8 weeks
+Patients with life expectancy >= 6 weeks
+Life expectancy severely limited by diseases other than malignancy
+Life expectancy > 12 weeks
+Life expectancy ?12 weeks
+Life expectancy >= 12 weeks
+Life expectancy severely limited by disease other than lymphoma
+Subject has predicted life expectancy ? 12 weeks in the opinion of the investigator.
+Life expectancy ? 12 weeks.
+Life expectancy of greater than 4 weeks
+Life expectancy of <3 weeks.
+Life expectancy of at least 12 weeks.
+Life expectancy of at least 12 weeks (3 months) as determined by the treating physician.
+Subject has life expectancy of more than 12 weeks
+Life expectancy > 12 weeks
+Subject has predicted life expectancy ? 12 weeks.
+Have an estimated life expectancy of ?12 weeks, in the judgment of the investigator
+Life expectancy of greater than 4 weeks
+Subjects must have a life expectancy of at least 12 weeks
+Life expectancy >= 12 weeks
+Life expectancy ? 12 weeks.
+Life-expectancy of at least 60 days
+Life expectancy ? 12 weeks.
+Life expectancy of at least 12 weeks
+Life expectancy of >/= 12 weeks
+Life expectancy of at least 12 weeks
+Life expectancy of ?12 weeks.
+Life expectancy of greater than 12 weeks
+Life expectancy of greater than 12 weeks
+Life expectancy of ? 12 weeks.
+Life expectancy of at least 12 weeks.
+Life expectancy 8 weeks or greater.
+Life expectancy of >= 12 weeks
+A minimum life expectancy of 12 weeks
+Predicted life expectancy ?12 weeks
+Life expectancy of greater than 12 weeks
+Life expectancy >12 weeks
+Life expectancy of greater than 12 weeks
+Life expectancy of >= 12 weeks, in the opinion of and as documented by the investigator
+Patients must have a life expectancy of greater than 20 weeks
+Life expectancy of > 12 weeks, in the opinion of and as documented by the investigator
+Patients must have a life expectancy of at least 10 weeks
+Patients must have a life expectancy of greater than 12 weeks
+Reasonable life-expectancy greater than 12 weeks
+Life expectancy >/=12 weeks
+Patients must have a life expectancy of at least 8 weeks
+Life expectancy of > 24 weeks
+Life expectancy of at least 12 weeks
+Life expectancy >= 12 weeks
+Life expectancy of ? 12 weeks.
+Life expectancy of at least 12 weeks
+Predicted life expectancy ? 12 weeks in the judgment of the investigator or sub-investigator.
+Life expectancy of greater than or equal to (>/=) 16 weeks
+Life expectancy of at least 12 weeks
+Life expectancy less than one year
+Life expectancy > or = 12 weeks
+Life expectancy > 12 weeks
+Life expectancy of greater than 16 weeks
+Life expectancy of at least 12 weeks from the first dose of study treatment
+Anticipated life expectancy of at least 12 weeks
+Patient must have a life expectancy of 8 weeks.
+Life expectancy >6mo.
+Life expectancy >= 12 weeks
+Life expectancy greater than or equal to (>=) 12 weeks
+Life expectancy of at least 12 weeks
+Life expectancy >= 8 weeks
+Life expectancy of greater than 12 weeks
+Life expectancy >= 12 weeks
+Subject must have a life expectancy > 12 weeks.
+Life expectancy of at least 12 weeks.
+In the opinion of the investigator, subjects who have a life expectancy fewer than 30 days.
+Life expectancy of at least 12 weeks
+Life expectancy >= 12 weeks
+Life expectancy of greater than 6 weeks
+Life expectancy of at least 12 weeks
+Life expectancy of >12 weeks
+- Life expectancy of at least 12 weeks
+Life expectancy > 12 weeks
+Patients must have a life expectancy of >= 8 weeks
+Patients must have a life expectancy of >= 8 weeks
+Life expectancy >12 weeks.
+Life expectancy of at least 12 weeks.
+Life expectancy 8 or more weeks.
+Anticipated life expectancy >12 weeks
+Life expectancy >= 12 weeks
+Patients must have a life expectancy of at least 12 weeks
+Life expectancy of at least 12 weeks
+Life expectancy >= 12 weeks
+Life expectancy greater than or equal to (>/=) 12 weeks
+A minimum life expectancy of 12 weeks
+Patients must have a life expectancy of at least 12 weeks
+Life expectancy of < 12 weeks
+Life expectancy ?12 weeks
+Life expectancy >=12 weeks
+Life expectancy at least 8 weeks
+Patients must have a life expectancy of at least 12 weeks.
+Life expectancy of greater than 12 weeks
+Estimated life expectancy greater than 5 years
+Estimated life expectancy of ? 26 weeks
+Life expectancy ? 12 weeks.
+Life expectancy > 12 weeks
+Life expectancy >= 12 weeks
+Life expectancy <12 weeks.
+Life expectancy of at least 24 weeks
+Life expectancy of at least 12 weeks
+Life expectancy of >= 12 weeks
+Life expectancy less than 12 weeks
+Life expectancy of > 12 weeks
+Estimated life expectancy of more than 12 weeks.
+Patient’s life expectancy is >= 10 years
+Life expectancy greater than or equal to (>=12 weeks)
+Life expectancy of greater than 12 weeks
+Life expectancy of > 12 weeks
+Life expectancy ? 12 weeks
+Life expectancy of greater than 12 weeks
+Life expectancy of at least 12 weeks
+Life expectancy greater than or equal to (>=) 12 weeks, in the opinion of the investigator
+Life expectancy greater than 12 weeks in the opinion of the Investigator
+Life expectancy > 12 weeks.
+Life expectancy of greater than 12 weeks
+Must have a Karnofsky performance status of > 50 with a predicted life expectancy of at least 12 weeks.
+Life expectancy of 12 weeks or greater
+Life expectancy of ? 12 weeks
+Anticipated life expectancy of >12 weeks
+Patients with other active malignancies (no evidence of other cancer or life expectancy greater than 5 years) are ineligible for this study
+Life expectancy of at least 1 month
+Estimated life expectancy of at least 12-weeks;
+Estimated life expectancy of at least 12-weeks;
+Life expectancy of >= 12 weeks
+Estimated life expectancy that will permit the participants to complete 8 weeks of treatment.
+ECOG Performance Status of ? 2 and life expectancy of ? 12 weeks.
+Life expectancy of at least 12 weeks
+Documented life expectancy of greater than 12 weeks
+The participant has an estimated life expectancy of at least 12 weeks.
+Life expectancy greater than or equal to (>/=) 12 weeks
+Estimated life expectancy of at least 12 weeks
+Life expectancy of ? 12 weeks
+Life expectancy of at least 12 weeks
+Life expectancy >= 12 weeks
+Patients must have a life expectancy > 11 weeks
+Patients must have a life expectancy > 8 weeks
+All patients must have an estimated life expectancy of at least 12 weeks
+Life Expectancy: Must be greater than 8 weeks
+Life expectancy: at least 8 weeks
+Life expectancy of ? 12 weeks.
+Life expectancy > 12 weeks
+Life expectancy ? 12 weeks
+The patient must have a life expectancy of at least 12 weeks
+Life expectancy of greater than 8 weeks
+Life expectancy >= 12 weeks
+Life expectancy of greater than 12 weeks
+Life expectancy greater than 10 years
+Life expectancy of >= 12 weeks
+Life expectancy >= 12 weeks
+Patients must have a life expectancy >= 8 weeks as determined by the enrolling investigator
+No co-existing medical conditions with life expectancy < 5 years
+PATIENT EXCLUSION: Life expectancy of < 1 month
+Patients must have a life expectancy > 12 weeks
+Patients must have a life expectancy of 100 days
+Life expectancy of greater than 8 weeks
+Life expectancy of greater than or equal to (?) 12 weeks
+Must have a life expectancy > 5 days
+There are no restrictions related to performance status or life expectancy
+Life expectancy of at least 12 weeks as deemed by the treating oncologist
+Patients are eligible regardless of life expectancy
+Patients with an expected life expectancy of less than 12 weeks
+No life expectancy restriction
+There are no restrictions related to performance status or life expectancy
+There are no restrictions related to performance status and life expectancy
+Life expectancy of less than 12 weeks
+All subjects must have a life expectancy of 12 weeks or more
+Life expectancy of at least one year
+Life expectancy >= 60 days
+Life expectancy of greater than 12 weeks
+Participants must have a life expectancy of 2 years or more
+Life expectancy of at least 12 weeks
+Life expectancy of greater than or equal to (>=) 16 weeks
+Life expectancy estimated to be at least 2 years
+Patients should have a life expectancy of at least 1 year
+Life expectancy < 12 weeks
+No restrictions will be made based on life expectancy
+Life expectancy of at least 12 weeks
+Life expectancy less than 5 years
+Patients with a life expectancy of less than one year
+Life expectancy of greater than 5 years
+Life expectancy of greater than 30 days
+Subjects with a life expectancy less than study duration;
+Life expectancy of at least 12 weeks
+Participant must have a life expectancy >= 16 weeks
+Patients with life expectancy >= 6 weeks
+Life expectancy of 12 weeks of greater based on assessment by the treating investigator
+Life expectancy of >= 5 years
+Life expectancy less than five years.
+Life expectancy of > 12 weeks
+Life expectancy of more than 12 weeks
+Life expectancy of more than 12 weeks
+Life expectancy of at least one year
+Life expectancy of less than one year.
+Life expectancy of greater than 10 weeks
+Life expectancy of greater than 4 weeks
+Life expectancy of >= 12 weeks as estimated by the treating physician
+Life expectancy >= 2 years
+Life expectancy of greater than 1 year
+Life expectancy of greater than 10 years
+Group I: Life expectancy >= 1 year
+Group II: Life expectancy >= 1 year
+Group III: Life expectancy >= 1 year
+Life expectancy of more than 12 weeks
+There are no life expectancy restrictions
+Subject must have a life expectancy that exceeds the duration of the clinical trial
+Patient must have a life expectancy of > 8 weeks
+Have life expectancy of more than 12 weeks
+Life expectancy of >= 12 weeks
+Life expectancy ? 12 weeks.
+Life expectancy >1 year. LGL-Specific:
+Life expectancy > 12 weeks.
+A life expectancy of greater than 24 weeks at Screening.
+Life expectancy ?12 weeks at Day 1.
+Patients must have a life expectancy of >= 6 weeks
+Life expectancy of >= 12 weeks, in the opinion of the investigator
+Life expectancy of more than 12 weeks
+Individuals with a short life expectancy (< 10 years)
+There are no restrictions on life expectancy
+Life expectancy is not a consideration for protocol entry
+Life expectancy of at least 12 weeks.
+Life expectancy >= 12 weeks
+Life expectancy of greater than 12 weeks
+Minimum life expectancy of at least 12 weeks.
+Has a life expectancy ?12 weeks from randomization.
+Life expectancy of <12 weeks
+Have an estimated life expectancy of ?12 weeks.
+Life expectancy of at least 12 weeks.